Clinical Trial Update: Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort

View source ↗

Summary

A completed clinical trial update detailing pharmacokinetic, immunological, and biochemical sample collection and analysis in a natalizumab-treated multiple scl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: John F. Foley, MD | Conditions: Multiple Sclerosis, Relapse | Status: COMPLETED